April 1, 2026 · Form 4 insider transaction
Mukunda Ram bought 33,332 shares of IGC Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
On February 3, 2026, the Reporting Person's spouse was granted RSUs.